Drug
R744
R744: highest development phase Phase 3, developed by Chugai. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| R744 NCT00433888 | Phase 3 | Hemodialysis Patients |
| R744 NCT00433849 | Phase 3 | Peritoneal Dialysis Patients |
Latest
No recent events.
Follow R744 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.